224 related articles for article (PubMed ID: 15969922)
1. Effect of chitosan on the intranasal absorption of salmon calcitonin in sheep.
Hinchcliffe M; Jabbal-Gill I; Smith A
J Pharm Pharmacol; 2005 Jun; 57(6):681-7. PubMed ID: 15969922
[TBL] [Abstract][Full Text] [Related]
2. Enhancement of nasal and intestinal calcitonin delivery by the novel Pheroid fatty acid based delivery system, and by N-trimethyl chitosan chloride.
du Plessis LH; Lubbe J; Strauss T; Kotzé AF
Int J Pharm; 2010 Jan; 385(1-2):181-6. PubMed ID: 19854253
[TBL] [Abstract][Full Text] [Related]
3. Enhancing effect of chitosan on nasal absorption of salmon calcitonin in rats: comparison with hydroxypropyl- and dimethyl-beta-cyclodextrins.
Sinswat P; Tengamnuay P
Int J Pharm; 2003 May; 257(1-2):15-22. PubMed ID: 12711157
[TBL] [Abstract][Full Text] [Related]
4. Methylated beta-cyclodextrins are able to improve the nasal absorption of salmon calcitonin.
Schipper NG; Verhoef JC; Romeijn SG; Merkus FW
Calcif Tissue Int; 1995 Apr; 56(4):280-2. PubMed ID: 7767838
[TBL] [Abstract][Full Text] [Related]
5. Prominent circadian absorption of intranasal salmon calcitonin (SCT) in healthy subjects.
Tarquini B; Cavallini V; Cariddi A; Checchi M; Sorice V; Cecchettin M
Chronobiol Int; 1988; 5(2):149-52. PubMed ID: 3401980
[TBL] [Abstract][Full Text] [Related]
6. Design of salmon calcitonin particles for nasal delivery using spray-drying and novel supercritical fluid-assisted spray-drying processes.
Cho W; Kim MS; Jung MS; Park J; Cha KH; Kim JS; Park HJ; Alhalaweh A; Velaga SP; Hwang SJ
Int J Pharm; 2015 Jan; 478(1):288-296. PubMed ID: 25445994
[TBL] [Abstract][Full Text] [Related]
7. The bioavailability of intranasal salmon calcitonin in healthy volunteers with and without a permeation enhancer.
Lee WA; Ennis RD; Longenecker JP; Bengtsson P
Pharm Res; 1994 May; 11(5):747-50. PubMed ID: 8058647
[TBL] [Abstract][Full Text] [Related]
8. Dose-response bioactivity and bioavailability of salmon calcitonin in premenopausal and postmenopausal women.
Overgaard K; Agnusdei D; Hansen MA; Maioli E; Christiansen C; Gennari C
J Clin Endocrinol Metab; 1991 Feb; 72(2):344-9. PubMed ID: 1846873
[TBL] [Abstract][Full Text] [Related]
9. Improved absorption of salmon calcitonin by ultraflexible liposomes through intranasal delivery.
Chen M; Li XR; Zhou YX; Yang KW; Chen XW; Deng Q; Liu Y; Ren LJ
Peptides; 2009 Jul; 30(7):1288-95. PubMed ID: 19540427
[TBL] [Abstract][Full Text] [Related]
10. Intranasal delivery of PEGylated salmon calcitonins: hypocalcemic effects in rats.
Lee KC; Park MO; Na DH; Youn YS; Lee SD; Yoo SD; Lee HS; DeLuca PP
Calcif Tissue Int; 2003 Dec; 73(6):545-9. PubMed ID: 14508623
[TBL] [Abstract][Full Text] [Related]
11. Optimizing bioavailability of oral administration of small peptides through pharmacokinetic and pharmacodynamic parameters: the effect of water and timing of meal intake on oral delivery of Salmon Calcitonin.
Karsdal MA; Byrjalsen I; Riis BJ; Christiansen C
BMC Clin Pharmacol; 2008 Sep; 8():5. PubMed ID: 18782439
[TBL] [Abstract][Full Text] [Related]
12. Improved nasal absorption of salmon calcitonin by powdery formulation with N-acetyl-L-cysteine as a mucolytic agent.
Matsuyama T; Morita T; Horikiri Y; Yamahara H; Yoshino H
J Control Release; 2006 Oct; 115(2):183-8. PubMed ID: 16989920
[TBL] [Abstract][Full Text] [Related]
13. A sandwich transfer enzyme immunoassay for salmon calcitonin: determination of the bioavailability of intranasal salmon calcitonin in human.
Kohno T; Murasugi N; Sakurai H; Watabe K; Nakamuta H; Koida M; Sugie Y; Nomura M; Yanagawa A
J Clin Lab Anal; 1997; 11(6):380-7. PubMed ID: 9406061
[TBL] [Abstract][Full Text] [Related]
14. [Study on pulmonary delivery system of salmon calcitonin in rats].
Wang Z; Zhang Q
Beijing Da Xue Xue Bao Yi Xue Ban; 2003 Jun; 35(3):329-32. PubMed ID: 12914259
[TBL] [Abstract][Full Text] [Related]
15. Intranasal delivery of recombinant human growth hormone (somatropin) in sheep using chitosan-based powder formulations.
Cheng YH; Dyer AM; Jabbal-Gill I; Hinchcliffe M; Nankervis R; Smith A; Watts P
Eur J Pharm Sci; 2005 Sep; 26(1):9-15. PubMed ID: 15970435
[TBL] [Abstract][Full Text] [Related]
16. Effect of nasal salmon calcitonin on calcium and bone metabolism.
Thamsborg G
Dan Med Bull; 1999 Apr; 46(2):118-26. PubMed ID: 10327295
[TBL] [Abstract][Full Text] [Related]
17. Nasal absorption and pharmacokinetic disposition of salmon calcitonin modified with low molecular weight polyethylene glycol.
Shin BS; Jung JH; Lee KC; Yoo SD
Chem Pharm Bull (Tokyo); 2004 Aug; 52(8):957-60. PubMed ID: 15304989
[TBL] [Abstract][Full Text] [Related]
18. Nasal insulin delivery in the chitosan solution: in vitro and in vivo studies.
Yu S; Zhao Y; Wu F; Zhang X; Lü W; Zhang H; Zhang Q
Int J Pharm; 2004 Aug; 281(1-2):11-23. PubMed ID: 15288339
[TBL] [Abstract][Full Text] [Related]
19. Hypocalcemic effect of salmon calcitonin following single and repeated nasal and intravenous administration in young rabbits.
Schipper NG; Romeijn SG; Verhoef J; Merkus FW
Calcif Tissue Int; 1994 Jan; 54(1):50-5. PubMed ID: 8118754
[TBL] [Abstract][Full Text] [Related]
20. Nasal administration of morphine-6-glucuronide in sheep--a pharmacokinetic study.
Illum L; Davis SS; Pawula M; Fisher AN; Barrett DA; Farraj NF; Shaw PN
Biopharm Drug Dispos; 1996 Nov; 17(8):717-24. PubMed ID: 8950049
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]